A collaborative program designed to treat thyroid eye disease (TED) at the University of Utah offers patients access to highly customized treatments—including a delicate endoscopic surgery at the Moran Eye...
Ocular inflammatory disease, including uveitis, scleritis, and orbital inflammatory disease, can be acute or chronic, infectious, non-infectious, or present as a masquerade syndrome. Therefore, its management is manifold, and a...
Cataract surgery in uveitis patients requires special consideration. Both intraocular inflammation and its first-line treatment (steroids) contribute to cataract progression, and cataracts are a main cause of decreased vision in...
Clinical updates from the John A. Moran Eye Center’s Uveitis Division, including a new CMV screening protocol, managing patient care amid the COVID-19 pandemic, ongoing clinical trials, and selected research...
Moran’s Global Outreach Division conducts large-scale surgical outreach with partners throughout the world to create sustainable eye care systems. However, Moran’s work goes beyond providing care. Through broad training initiatives...
At the John A. Moran Eye Center, your safety is our primary concern. Since mid-March, we have limited patient access to Moran clinics to do our part to help prevent...
The University of Utah School of Medicine Alumni Association has chosen John A. Moran Eye Center physician-researcher Nick Mamalis, MD, to receive its 2020 Distinguished Alumni Award.
While the coronavirus pandemic has temporarily halted routine exams and surgeries, the John A. Moran Eye Center continues to provide essential, urgent treatments for conditions like age-related degeneration—with extra precautions...
The John A. Moran Eye Center continues to provide sight-saving outreach care to Utah’s homeless and low-income communities during the COVID-19 pandemic.
Continuing work to make eye care more accessible in Tanzania, the John A. Moran Eye Center's Global Outreach Division conducted a second Allied Ophthalmic Training Program mission in February.